drugset / Trial / NCT00914121

Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)

NCT00914121

Phase 1 Completed 60 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to examine the effect of SKI-606 on rhythms of the heart (cardiac repolarization)

Timeline

Start
2009-06
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Bosutinib Small molecule
Comparator Moxifloxacin Small molecule

Indications

No indication recorded.